82 FR 10372 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 82, Issue 27 (February 10, 2017)

Page Range		10372-10373
FR Document		2017-02784

The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http:// www.samhsa.gov/workplace.

Federal Register, Volume 82 Issue 27 (Friday, February 10, 2017)

[Federal Register Volume 82, Number 27 (Friday, February 10, 2017)]
[Notices]
[Pages 10372-10373]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-02784]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Current List of HHS-Certified Laboratories and Instrumented 
Initial Testing Facilities Which Meet Minimum Standards To Engage in 
Urine Drug Testing for Federal Agencies

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) notifies 
federal agencies of the laboratories and Instrumented Initial Testing 
Facilities (IITF) currently certified to meet the standards of the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs 
(Mandatory Guidelines).
    A notice listing all currently HHS-certified laboratories and IITFs 
is published in the Federal Register during the first week of each 
month. If any laboratory or IITF certification is suspended or revoked, 
the laboratory or IITF will be omitted from subsequent lists until such 
time as it is restored to full certification under the Mandatory 
Guidelines.
    If any laboratory or IITF has withdrawn from the HHS National 
Laboratory Certification Program (NLCP) during the past month, it will 
be listed at the end and will be omitted from the monthly listing 
thereafter.
    This notice is also available on the Internet at http://www.samhsa.gov/workplace.

FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace 
Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, 
Maryland 20857; 240-276-2600 (voice).

SUPPLEMENTARY INFORMATION: The Department of Health and Human Services 
(HHS) notifies federal agencies of the laboratories and Instrumented 
Initial Testing Facilities (IITF) currently certified to meet the 
standards of the Mandatory Guidelines for Federal Workplace Drug 
Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were 
first published in the Federal Register on April 11, 1988 (53 FR 
11970), and subsequently revised in the Federal Register on June 9, 
1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 
(69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 
FR 75122); and on April 30, 2010 (75 FR 22809).
    The Mandatory Guidelines were initially developed in accordance 
with Executive Order 12564 and section 503 of Public Law 100-71. The 
``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' 
as amended in the revisions listed above, requires strict standards 
that laboratories and IITFs must meet in order to conduct drug and 
specimen validity tests on urine specimens for federal agencies.
    To become certified, an applicant laboratory or IITF must undergo 
three rounds of performance testing plus an on-site inspection. To 
maintain that certification, a laboratory or IITF must participate in a 
quarterly performance testing program plus undergo periodic, on-site 
inspections.
    Laboratories and IITFs in the applicant stage of certification are 
not to be considered as meeting the minimum requirements described in 
the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must 
have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), 
which attests that it has met minimum standards.
    In accordance with the Mandatory Guidelines dated November 25, 2008 
(73 FR 71858), the following HHS-

[[Page 10373]]

certified laboratories and IITFs meet the minimum standards to conduct 
drug and specimen validity tests on urine specimens:

HHS-Certified Instrumented Initial Testing Facilities

Dynacare, 6628 50th Street NW., Edmonton, AB Canada T6B 2N7, 780-784-
1190, (Formerly: Gamma-Dynacare Medical Laboratories).

HHS-Certified Laboratories

ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 
844-486-9226.
Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN 
37210, 615-255-2400, (Formerly: Aegis Sciences Corporation, Aegis 
Analytical Laboratories, Inc., Aegis Analytical Laboratories).
Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361-
8989/800-433-3823, (Formerly: Kroll Laboratory Specialists, Inc., 
Laboratory Specialists, Inc.).
Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 
804-378-9130, (Formerly: Kroll Laboratory Specialists, Inc., Scientific 
Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, 
Inc.).
Baptist Medical Center--Toxicology Laboratory, 11401 I-30, Little Rock, 
AR 72209-7056, 501-202-2783, (Formerly: Forensic Toxicology Laboratory 
Baptist Medical Center).
Clinical Reference Laboratory, Inc., 8433 Quivira Road, Lenexa, KS 
66215-2802, 800-445-6917.
DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800-
235-4890.
Dynacare *, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679-
1630, (Formerly: Gamma--Dynacare Medical Laboratories).
---------------------------------------------------------------------------

    * The Standards Council of Canada (SCC) voted to end its 
Laboratory Accreditation Program for Substance Abuse (LAPSA) 
effective May 12, 1998. Laboratories certified through that program 
were accredited to conduct forensic urine drug testing as required 
by U.S. Department of Transportation (DOT) regulations. As of that 
date, the certification of those accredited Canadian laboratories 
will continue under DOT authority. The responsibility for conducting 
quarterly performance testing plus periodic on-site inspections of 
those LAPSA-accredited laboratories was transferred to the U.S. HHS, 
with the HHS' NLCP contractor continuing to have an active role in 
the performance testing and laboratory inspection processes. Other 
Canadian laboratories wishing to be considered for the NLCP may 
apply directly to the NLCP contractor just as U.S. laboratories do.
    Upon finding a Canadian laboratory to be qualified, HHS will 
recommend that DOT certify the laboratory (Federal Register, July 
16, 1996) as meeting the minimum standards of the Mandatory 
Guidelines published in the Federal Register on November 25, 2008 
(73 FR 71858). After receiving DOT certification, the laboratory 
will be included in the monthly list of HHS-certified laboratories 
and participate in the NLCP certification maintenance program.
---------------------------------------------------------------------------

ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 
662-236-2609.
Fortes Laboratories, Inc., 25749 SW Canyon Creek Road, Suite 600, 
Wilsonville, OR 97070, 503-486-1023.
Laboratory Corporation of America Holdings, 7207 N. Gessner Road, 
Houston, TX 77040, 713-856-8288/800-800-2387.
Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 
08869, 908-526-2400/800-437-4986, (Formerly: Roche Biomedical 
Laboratories, Inc.).
Laboratory Corporation of America Holdings, 1904 Alexander Drive, 
Research Triangle Park, NC 27709, 919-572-6900/800-833-3984, (Formerly: 
LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, 
Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical 
Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche 
Group).
Laboratory Corporation of America Holdings, 1120 Main Street, 
Southaven, MS 38671, 866-827-8042/800-233-6339, (Formerly: LabCorp 
Occupational Testing Services, Inc.; MedExpress/National Laboratory 
Center).
LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 
66219, 913-888-3927/800-873-8845, (Formerly: Quest Diagnostics 
Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division 
of LabOne, Inc.).
MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 
651-636-7466/800-832-3244.
MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 
97232, 503-413-5295/800-950-5295.
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology 
Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088, 
Testing for Veterans Affairs (VA) Employees Only.
National Toxicology Laboratories, Inc., 1100 California Ave., 
Bakersfield, CA 93304, 661-322-4250/800-350-3515.
One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, 
TX 77504, 888-747-3774, (Formerly: University of Texas Medical Branch, 
Clinical Chemistry Division; UTMB Pathology--Toxicology Laboratory).
Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 
91311, 800-328-6942, (Formerly: Centinela Hospital Airport Toxicology 
Laboratory).
Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, 
WA 99204, 509-755-8991/800-541-7891x7.
Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635-
5840.
Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 
800-729-6432, (Formerly: SmithKline Beecham Clinical Laboratories; 
SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 
610-631-4600/877-642-2216, (Formerly: SmithKline Beecham Clinical 
Laboratories; SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 8401 Fallbrook Ave., West Hills, CA 
91304, 818-737-6370, (Formerly: SmithKline Beecham Clinical 
Laboratories).
Redwood Toxicology Laboratory, 3700 Westwind Blvd., Santa Rosa, CA 
95403, 800-255-2159.
STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 
98421, 800-442-0438.
U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., 
Fort George G. Meade, MD 20755-5235, 301-677-7085, Testing for 
Department of Defense (DoD) Employees Only.

    The following laboratory has voluntarily withdrawn from the 
National Laboratory Certification Program, as of January 6, 2017:

Southwest Laboratories, 4625 E. Cotton Center Boulevard, Suite 177, 
Phoenix, AZ 85040, 602-438-8507/800-279-0027.

Charles LoDico,
Chemist.
[FR Doc. 2017-02784 Filed 2-9-17; 8:45 am]
 BILLING CODE 4160-20-P

10372 Federal Register / Vol. 82, No. 27 / Friday, February 10, 2017 / Notices

confidential trade secrets or commercial Agenda: To review and evaluate grant suspended or revoked, the laboratory or
property such as patentable material, applications. IITF will be omitted from subsequent
and personal information concerning Place: National Institutes of Health, 5601 lists until such time as it is restored to
Fishers Lane, Rockville, MD 20892
individuals associated with the grant full certification under the Mandatory
(Telephone Conference Call).
applications, the disclosure of which Contact Person: Andrea L. Wurster, Ph.D., Guidelines.
would constitute a clearly unwarranted Scientific Review Officer, Scientific Review If any laboratory or IITF has
invasion of personal privacy. Program, Division of Extramural Activities, withdrawn from the HHS National
Name of Committee: Heart, Lung, and Room 3G33B, National Institutes of Health, Laboratory Certification Program (NLCP)
Blood Initial Review Group; Clinical Trials NIAID, 5601 Fishers Lane, MSC 9823, during the past month, it will be listed
Review Committee. Bethesda, MD 20892–9823, (240) 669–5062, at the end and will be omitted from the
Date: March 9–10, 2017. wurstera@mail.nih.gov. monthly listing thereafter.
Time: 8:00 a.m. to 5:00 p.m. Name of Committee:National Institute of This notice is also available on the
Agenda: To review and evaluate grant Allergy and Infectious Diseases Special Internet at http://www.samhsa.gov/
applications. Emphasis Panel; NIAID Investigator Initiated workplace.
Place: Hilton Garden Inn Bethesda, 7301 Program Project Applications (P01).
Waverly Street, Bethesda, MD 20814. Date: March 9, 2017. FOR FURTHER INFORMATION CONTACT:
Contact Person: Keary A. Cope, Ph.D., Time: 1:00 p.m. to 5:00 p.m. Giselle Hersh, Division of Workplace
Scientific Review Officer, Office of Scientific Agenda: To review and evaluate grant Programs, SAMHSA/CSAP, 5600
Review/DERA, National Heart, Lung, and applications. Fishers Lane, Room 16N03A, Rockville,
Blood Institute, 6701 Rockledge Drive, Room Place: National Institutes of Health, 5601 Maryland 20857; 240–276–2600 (voice).
7190, Bethesda, MD 20892–7924, 301–827– Fishers Lane, Rockville, MD 20892
7912, copeka@mail.nih.gov. (Telephone Conference Call). SUPPLEMENTARY INFORMATION: The
(Catalogue of Federal Domestic Assistance Contact Person: Andrea L. Wurster, Ph.D., Department of Health and Human
Program Nos. 93.233, National Center for Scientific Review Officer, Scientific Review Services (HHS) notifies federal agencies
Sleep Disorders Research; 93.837, Heart and Program, Division of Extramural Activities, of the laboratories and Instrumented
Vascular Diseases Research; 93.838, Lung Room 3G33B, National Institutes of Health, Initial Testing Facilities (IITF) currently
Diseases Research; 93.839, Blood Diseases NIAID, 5601 Fishers Lane, MSC 9823, certified to meet the standards of the
and Resources Research, National Institutes Bethesda, MD 20892–9823, (240) 669–5062, Mandatory Guidelines for Federal
of Health, HHS) wurstera@mail.nih.gov. Workplace Drug Testing Programs
Dated: February 6, 2017. (Catalogue of Federal Domestic Assistance (Mandatory Guidelines). The Mandatory
Michelle Trout, Program Nos. 93.855, Allergy, Immunology, Guidelines were first published in the
and Transplantation Research; 93.856, Federal Register on April 11, 1988 (53
Program Analyst, Office of Federal Advisory
Microbiology and Infectious Diseases FR 11970), and subsequently revised in
Committee Policy.
Research, National Institutes of Health, HHS)
[FR Doc. 2017–02722 Filed 2–9–17; 8:45 am] the Federal Register on June 9, 1994 (59
Dated: February 6, 2017. FR 29908); September 30, 1997 (62 FR
BILLING CODE 4140–01–P
Natasha M. Copeland, 51118); April 13, 2004 (69 FR 19644);
Program Analyst, Office of Federal Advisory November 25, 2008 (73 FR 71858);
DEPARTMENT OF HEALTH AND Committee Policy. December 10, 2008 (73 FR 75122); and
HUMAN SERVICES [FR Doc. 2017–02726 Filed 2–9–17; 8:45 am] on April 30, 2010 (75 FR 22809).
BILLING CODE 4140–01–P The Mandatory Guidelines were
National Institutes of Health initially developed in accordance with
Executive Order 12564 and section 503
National Institute of Allergy and DEPARTMENT OF HEALTH AND of Public Law 100–71. The ‘‘Mandatory
Infectious Diseases; Notice of Closed HUMAN SERVICES Guidelines for Federal Workplace Drug
Meetings Testing Programs,’’ as amended in the
Substance Abuse and Mental Health revisions listed above, requires strict
Pursuant to section 10(d) of the
Services Administration standards that laboratories and IITFs
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is must meet in order to conduct drug and
Current List of HHS-Certified specimen validity tests on urine
hereby given of the following meetings. Laboratories and Instrumented Initial
The meetings will be closed to the specimens for federal agencies.
Testing Facilities Which Meet Minimum To become certified, an applicant
public in accordance with the Standards To Engage in Urine Drug
provisions set forth in sections laboratory or IITF must undergo three
Testing for Federal Agencies rounds of performance testing plus an
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and AGENCY: Substance Abuse and Mental on-site inspection. To maintain that
the discussions could disclose Health Services Administration, HHS. certification, a laboratory or IITF must
confidential trade secrets or commercial ACTION: Notice. participate in a quarterly performance
property such as patentable material, testing program plus undergo periodic,
and personal information concerning SUMMARY: The Department of Health and on-site inspections.
individuals associated with the grant Human Services (HHS) notifies federal Laboratories and IITFs in the
applications, the disclosure of which agencies of the laboratories and applicant stage of certification are not to
would constitute a clearly unwarranted Instrumented Initial Testing Facilities be considered as meeting the minimum
invasion of personal privacy. (IITF) currently certified to meet the requirements described in the HHS
standards of the Mandatory Guidelines Mandatory Guidelines. A HHS-certified
mstockstill on DSK3G9T082PROD with NOTICES

Name of Committee: National Institute of for Federal Workplace Drug Testing laboratory or IITF must have its letter of
Allergy and Infectious Diseases Special
Programs (Mandatory Guidelines). certification from HHS/SAMHSA
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01) and
A notice listing all currently HHS- (formerly: HHS/NIDA), which attests
NIAID Resource-Related Research Projects certified laboratories and IITFs is that it has met minimum standards.
(R24). published in the Federal Register In accordance with the Mandatory
Date: March 7, 2017. during the first week of each month. If Guidelines dated November 25, 2008
Time: 10:00 a.m. to 2:00 p.m. any laboratory or IITF certification is (73 FR 71858), the following HHS-

VerDate Sep<11>2014 18:35 Feb 09, 2017 Jkt 241001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\10FEN1.SGM 10FEN1

Federal Register / Vol. 82, No. 27 / Friday, February 10, 2017 / Notices 10373

certified laboratories and IITFs meet the 679–1630, (Formerly: Gamma— 800–328–6942, (Formerly: Centinela
minimum standards to conduct drug Dynacare Medical Laboratories). Hospital Airport Toxicology
and specimen validity tests on urine ElSohly Laboratories, Inc., 5 Industrial Laboratory).
specimens: Park Drive, Oxford, MS 38655, 662– Pathology Associates Medical
236–2609. Laboratories, 110 West Cliff Dr.,
HHS-Certified Instrumented Initial Fortes Laboratories, Inc., 25749 SW Spokane, WA 99204, 509–755–8991/
Testing Facilities Canyon Creek Road, Suite 600, 800–541–7891x7.
Dynacare, 6628 50th Street NW., Wilsonville, OR 97070, 503–486– Phamatech, Inc., 15175 Innovation
Edmonton, AB Canada T6B 2N7, 780– 1023. Drive, San Diego, CA 92128, 888–
784–1190, (Formerly: Gamma- Laboratory Corporation of America 635–5840.
Dynacare Medical Laboratories). Holdings, 7207 N. Gessner Road, Quest Diagnostics Incorporated, 1777
Houston, TX 77040, 713–856–8288/ Montreal Circle, Tucker, GA 30084,
HHS-Certified Laboratories
800–800–2387. 800–729–6432, (Formerly: SmithKline
ACM Medical Laboratory, Inc., 160 Laboratory Corporation of America Beecham Clinical Laboratories;
Elmgrove Park, Rochester, NY 14624, Holdings, 69 First Ave., Raritan, NJ SmithKline Bio-Science Laboratories).
844–486–9226. 08869, 908–526–2400/800–437–4986, Quest Diagnostics Incorporated, 400
Aegis Analytical Laboratories, Inc., 345 (Formerly: Roche Biomedical Egypt Road, Norristown, PA 19403,
Hill Ave., Nashville, TN 37210, 615– Laboratories, Inc.). 610–631–4600/877–642–2216,
255–2400, (Formerly: Aegis Sciences Laboratory Corporation of America (Formerly: SmithKline Beecham
Corporation, Aegis Analytical Holdings, 1904 Alexander Drive, Clinical Laboratories; SmithKline Bio-
Laboratories, Inc., Aegis Analytical Research Triangle Park, NC 27709, Science Laboratories).
Laboratories). 919–572–6900/800–833–3984, Quest Diagnostics Incorporated, 8401
Alere Toxicology Services, 1111 Newton (Formerly: LabCorp Occupational Fallbrook Ave., West Hills, CA 91304,
St., Gretna, LA 70053, 504–361–8989/ Testing Services, Inc., CompuChem 818–737–6370, (Formerly: SmithKline
800–433–3823, (Formerly: Kroll Laboratories, Inc.; CompuChem Beecham Clinical Laboratories).
Laboratory Specialists, Inc., Laboratories, Inc., A Subsidiary of Redwood Toxicology Laboratory, 3700
Laboratory Specialists, Inc.). Roche Biomedical Laboratory; Roche Westwind Blvd., Santa Rosa, CA
Alere Toxicology Services, 450 CompuChem Laboratories, Inc., A 95403, 800–255–2159.
Southlake Blvd., Richmond, VA Member of the Roche Group). STERLING Reference Laboratories, 2617
23236, 804–378–9130, (Formerly: Laboratory Corporation of America East L Street, Tacoma, Washington
Kroll Laboratory Specialists, Inc., Holdings, 1120 Main Street, 98421, 800–442–0438.
Scientific Testing Laboratories, Inc.; Southaven, MS 38671, 866–827–8042/ U.S. Army Forensic Toxicology Drug
Kroll Scientific Testing Laboratories, 800–233–6339, (Formerly: LabCorp Testing Laboratory, 2490 Wilson St.,
Inc.). Occupational Testing Services, Inc.; Fort George G. Meade, MD 20755–
Baptist Medical Center—Toxicology MedExpress/National Laboratory 5235, 301–677–7085, Testing for
Laboratory, 11401 I–30, Little Rock, Center). Department of Defense (DoD)
AR 72209–7056, 501–202–2783, LabOne, Inc. d/b/a Quest Diagnostics, Employees Only.
(Formerly: Forensic Toxicology 10101 Renner Blvd., Lenexa, KS The following laboratory has
Laboratory Baptist Medical Center). 66219, 913–888–3927/800–873–8845, voluntarily withdrawn from the
Clinical Reference Laboratory, Inc., 8433 (Formerly: Quest Diagnostics National Laboratory Certification
Quivira Road, Lenexa, KS 66215– Incorporated; LabOne, Inc.; Center for Program, as of January 6, 2017:
2802, 800–445–6917. Laboratory Services, a Division of
DrugScan, Inc., 200 Precision Road, Southwest Laboratories, 4625 E. Cotton
LabOne, Inc.). Center Boulevard, Suite 177, Phoenix,
Suite 200, Horsham, PA 19044, 800– MedTox Laboratories, Inc., 402 W.
235–4890. AZ 85040, 602–438–8507/800–279–
County Road D, St. Paul, MN 55112, 0027.
Dynacare *, 245 Pall Mall Street, 651–636–7466/800–832–3244.
London, ONT, Canada N6A 1P4, 519– MetroLab-Legacy Laboratory Services, Charles LoDico,
1225 NE 2nd Ave., Portland, OR Chemist.
* The Standards Council of Canada (SCC) voted
to end its Laboratory Accreditation Program for 97232, 503–413–5295/800–950–5295. [FR Doc. 2017–02784 Filed 2–9–17; 8:45 am]
Substance Abuse (LAPSA) effective May 12, 1998. Minneapolis Veterans Affairs Medical BILLING CODE 4160–20–P
Laboratories certified through that program were Center, Forensic Toxicology
accredited to conduct forensic urine drug testing as Laboratory, 1 Veterans Drive,
required by U.S. Department of Transportation
(DOT) regulations. As of that date, the certification Minneapolis, MN 55417, 612–725– DEPARTMENT OF HOMELAND
of those accredited Canadian laboratories will 2088, Testing for Veterans Affairs SECURITY
continue under DOT authority. The responsibility (VA) Employees Only.
for conducting quarterly performance testing plus National Toxicology Laboratories, Inc., Coast Guard
periodic on-site inspections of those LAPSA-
accredited laboratories was transferred to the U.S.
1100 California Ave., Bakersfield, CA
[Docket No. USCG–2016–0281]
HHS, with the HHS’ NLCP contractor continuing to 93304, 661–322–4250/800–350–3515.
have an active role in the performance testing and One Source Toxicology Laboratory, Inc., Collection of Information Under
laboratory inspection processes. Other Canadian 1213 Genoa–Red Bluff, Pasadena, TX
laboratories wishing to be considered for the NLCP Review by Office of Management and
may apply directly to the NLCP contractor just as
77504, 888–747–3774, (Formerly: Budget; OMB Control Number: 1625—
mstockstill on DSK3G9T082PROD with NOTICES

U.S. laboratories do. University of Texas Medical Branch, New
Upon finding a Canadian laboratory to be Clinical Chemistry Division; UTMB
qualified, HHS will recommend that DOT certify Pathology—Toxicology Laboratory). AGENCY:Coast Guard, DHS.
the laboratory (Federal Register, July 16, 1996) as Pacific Toxicology Laboratories, 9348 Thirty-day notice requesting
ACTION:
meeting the minimum standards of the Mandatory
Guidelines published in the Federal Register on DeSoto Ave., Chatsworth, CA 91311, comments.
November 25, 2008 (73 FR 71858). After receiving
DOT certification, the laboratory will be included participate in the NLCP certification maintenance SUMMARY: In compliance with the
in the monthly list of HHS-certified laboratories and program. Paperwork Reduction Act of 1995 the

VerDate Sep<11>2014 18:35 Feb 09, 2017 Jkt 241001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\10FEN1.SGM 10FEN1

Document Created: 2017-02-11 18:15:03
Document Modified: 2017-02-11 18:15:03

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice).
FR Citation		82 FR 10372

82 FR 10372 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICESSubstance Abuse and Mental Health Services Administration

Federal Register Volume 82, Issue 27 (February 10, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration